Concepedia

Stephan Schwers

SS

Statistics

Publications

16

Citations

1.4K

H-Index

14

Active since

1997

Affiliations

Bayer (Germany)(Current)

Clinical Research Services

University of Cologne

University Medical Center of the Johannes Gutenberg University Mainz

Maastricht University

Stephan Schwers is an author at Bayer (Germany) specializing in clinical pharmacology, pharmacology, and anticoagulant therapy.

Publications per year

1997–2024

16

Publications

16

Receptor Editing in a Transgenic Mouse Model: Site, Efficiency, and Role in B Cell Tolerance and Antibody Diversification

Roberta Pelanda, Stephan Schwers, Eiichiro Sonoda et al. · Immunity · 1997 · 291 citations · Full text

Life Sciences, Genetics, Molecular Biology +17

B Cell Development under the Condition of Allelic Inclusion

Eiichiro Sonoda, Yael Pewzner‐Jung, Stephan Schwers et al. · Immunity · 1997 · 245 citations · Full text

Life Sciences, Genetics, Immunology +14

Rivaroxaban and other novel oral anticoagulants: pharmacokinetics in healthy subjects, specific patient populations and relevance of coagulation monitoring

Wolfgang Mueck, Stephan Schwers, Jan Stampfuss · Thrombosis Journal · 2013 · 166 citations · Full text

Pharmacy, Pharmacokinetics, Pharmacology +17

Accurate determination of rivaroxaban levels requires different calibrator sets but not addition of antithrombin

Gabriele Rohde, Gertrud Stratmann, Christian W. Hesse et al. · Thrombosis and Haemostasis · 2012 · 99 citations

Medicine, Pharmaceutical Analysis, Pharmacology +15

First evaluation of the safety, pharmacokinetics, and pharmacodynamics of BAY 2433334, a small molecule targeting coagulation factor XIa

Dirk Thomas, Friederike Kanefendt, Stephan Schwers et al. · Journal of Thrombosis and Haemostasis · 2021 · 81 citations · Full text

Medicine, Pharmacokinetics, Pharmacology +14

1–5 of 16